267
Views
2
CrossRef citations to date
0
Altmetric
Editorials

What evidence is there for the role of vitamin D and apoA-1 in atheroprotection?

&
Pages 255-257 | Published online: 18 Jan 2017

Bibliography

  • Holick MF. Vitamin D: evolutionary, physiological and health perspectives. Curr. Drug Targets 12(1), 4–18 (2011)
  • Haas MJ, Mooradian AD. Inflammation, high-density lipoprotein and cardiovascular dysfunction. Curr. Opin Infect. Dis. 24(3), 265–272 (2011)
  • Haas MJ, Mooradian AD. Therapeutic interventions to enhance apolipoprotein A?Imediated cardioprotection. Drugs 70(7), 805–821 (2010)
  • Auwerx J, Bouillon R, Kesteloot H. Relationship between 25-hydroxyvitamin D3, apolipoprotein A?I, and high-density lipoprotein cholesterol. Arterioscler. Thromb. 12(6), 671–674 (1992)
  • John WG, Noonan K, Mannan N, Boucher B. Hypovitaminosis D is associated with reductions in serum apolipoprotein A?I but with fasting lipids in British Bangladeshis. Am. J. Clin. Nutr. 82(3), 517–522 (2005)
  • Devlin EE, Lambert M, Levy E et al. Vitamin D status is modestly associated with glycemia and indicators of lipid metabolism in French–Canadian children and adolescents. J. Nutr. 149(5), 987–991 (2010)
  • Williams DM, Fraser A, Sayers A et al. Associations of 25?hydroxyvitamin D2 and D3 with cardiovascular risk factors in childhood: cross-sectional findings from the Avon Longitudinal Study of Parents and Children. J. Clin. Endocrin. Metabol. doi:10.1210/jc.2011-2335 (2012) (Epub ahead of print)
  • Anderson R, Brot C, Mejborn H et al. Vitamin D supplementation does not affect serum lipids and lipoproteins in Pakistani immigrants. Eur. J. Clin. Nutr. 63(9), 1150–1153 (2009)
  • Jorde R, Sneve M, Torjesen P, Figenschau Y. No improvement in cardiovascular risk factors in overweight and obese subjects after supplementation with vitamin D3 for 1 year. J. Intern. Med. 267(5), 462–472 (2010)
  • Carbone LD, Rosenberg EW, Tolley EA et al. 25?hydroxyvitamin D, cholesterol, and ultraviolet radiation. Metabolism 57(6), 741–748 (2008)
  • Wehmeier K, Beers A, Haas MJ et al. Inhibition of apolipoprotein A?I gene expression by 1,25-dihydroxyvitamin D3. Biochim. Biophys. Acta 1737(1), 16–26 (2005)
  • Wehmeier KR, Mazza A, Hachem S et al. Differential regulation of apolipoprotein A?I gene expression by vitamin D receptor modulators. Biochim. Biophys. Acta 1780(2), 264–273 (2008)
  • Wehmeier K, Alamir A, Sultan S, Haas MJ, Wong NCW, Mooradian AD. 24,25-dihydroxycholecalciferol but not 25-hydroxycholecalciferol suppresses apolipoprotein A?I gene expression. Life Sci. 88(1–2), 110–116 (2011)
  • Wang J, Keisala T, Solakivi T, Minasyan A, Kalueff AV, Tuohimaa P. Serum cholesterol and expression of apo AI, LXRb, and SREBP2 in vitamin D receptor knockout mice. J. Steroid Biochem. Mol. Biol. 113(3–5), 222–226 (2009)
  • Oh J, Weng S, Felton SK et al. 1,25-(OH)2 vitamin D inhibits foam cell formation and suppresses macrophage cholesterol uptake in patients with Type 2 diabetes mellitus. Circulation 120(8), 687–698 (2009)
  • Wolfs IM, Donners MM, de Winther MP. Differentiation factors and cytokines in the atherosclerotic plaque micro-environment as a trigger for macrophage polarization. Thromb. Haemost. 106(5), 763–771 (2011)
  • Zhang Y, Leung DY, Richers BN et al. Vitamin D inhibits monocyte/macrophage proinflammatory cytokine production by targeting MAPK phosphatise?1. J. Immunol. 188(5), 2127–2135 (2012)
  • George N, Peeyush Kumar T, Antony S, Jayanarayanan S, Paulose CS. Effect of vitamin D3 in reducing metabolic and oxidative stress in the liver of streptozotocininduced diabetic rats. Br. J. Nutr. doi:10.1017/S0007114511006830 (2012) (Epub ahead of print)
  • Syed JH, Wang J, Wang S, Mooradian AD, Haas MJ. Inhibition of endoplasmic reticulum stress by vitamin D in endothelial cells. J. Invest. Med. 60(1), 435 (2012)
  • Laaksonen MA, Knekt P, Rissanen H et al. The relative importance of modifiable potential risk factors of Type 2 diabetes: a meta-analysis of two cohorts. Eur. J. Epidemiol. 25(2), 115–124 (2010)
  • Grandi NC, Breitiling LP, Brenner H. Vitamin D and cardiovascular disease: systematic review and meta-analysis of prospective studies. Prev. Med. 51(3–4), 228–233 (2010).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.